VivoSeq
Other

ALD

0

Pipeline Programs↗

5

Active Trials↗

5

Companies Involved↗

ALD is an early-stage landscape with 0 programs across 5 companies. The most active players are Ashvattha Therapeutics, Inc., Novartis, Shionogi.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Ashvattha Therapeutics, Inc.

0 programs

PreclinicalNovartis logo

Novartis

0 programs

PreclinicalShionogi logo

Shionogi

0 programs

PreclinicalP

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed10 · 56%
Recruiting3 · 17%
Not yet recruiting2 · 11%
Terminated2 · 11%
Unknown status1 · 6%

Clinical Trials

Trial Activity

18 trials

Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Recruiting·YYale University·Phase 4·NCT07281014·20 enrolled
Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Recruiting·HHospices Civils de Lyon·Phase 2·NCT03593317·120 enrolled
LGG Supplementation in Patients With AUD and ALD
Recruiting·UUniversity of Louisville·Phase 2·NCT05178069·60 enrolled
Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers
Not yet recruiting·AAshvattha Therapeutics, Inc.·Phase 1·NCT07370155·36 enrolled
Tirzepatide in MetALD
Not yet recruiting·National Institute on Alcohol Abuse and Alcoholism (NIAAA)·Phase 2·NCT07046819·120 enrolled
A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT02605798·24 enrolled
A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT03062423·36 enrolled
A Bio-equivalence Study of Sofosbuvir From Magicbuvir 400 mg Film Coated Tablets ( Magic Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)
Completed·GGenuine Research Center, Egypt·Phase 1·NCT02953535·36 enrolled
Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
Completed·UUniversitaire Ziekenhuizen KU Leuven·N/A·NCT05654298·20 enrolled
To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
Completed·Novartis logoNovartis·Phase 1·NCT00946491·30 enrolled
Long Term Safety of Naldemedine
Completed·Shionogi logoShionogi·Phase 3·NCT01965652·1,246 enrolled
Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity
Completed·PPfizer's Upjohn has merged with Mylan to form Viatris Inc.·Phase 1·NCT00990223·20 enrolled
The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production
Completed·—·Phase 1·NCT02871648·23 enrolled
Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.
Completed·UUniversitaire Ziekenhuizen KU Leuven·N/A·NCT04399525·12 enrolled
China Post-marketing Surveillance (PMS) Study of Aldurazyme®
Completed·Sanofi logoSanofi·Phase 4·NCT05134571·12 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)